Skip to content

Arthi Kovvali, DO

NPI 1679197461ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Galveston, TX

Internal Medicine, Endocrinology, Diabetes & Metabolism (DO) in Galveston, Texas, licensed in TX, with an NPI issued in June 2020. Part D covered 68 prescriptions written in 2024, 84% of them generic. Alexion Pharmaceuticals, Inc. was the largest of 10 companies reporting payments in 2025, $471.92 in all, mostly food and beverage.

Overview

NPI1679197461
StatusActive
Entity typeIndividual
CredentialDO
Sole proprietorNo
NPI issuedJun 8, 2020
Last updated in NPPESMay 20, 2025
Certified by providerMay 20, 2025

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)68 · 159 30-day fills
Patients26
Total drug cost$15,721
Generic share84% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$471.92 · 11 payments from 10 companies
  • 2024$89.01 · 4 payments from 4 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$471.92 · 11 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Galveston

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Texas →